Literature DB >> 23642451

Extraskeletal osteosarcoma: a very rare case report of primary tumor of the colon-rectum and review of the literature.

G Iannaci1, R Luise, P Sapere, R M A Costanzo, R Rossiello.   

Abstract

Extraskeletal osteosarcoma (ESOS) is a malignant mesenchymal tumor in which neoplastic cells produce bone osteoid in variable amounts. An 81-year-old woman presented with severe abdominal pain, tenesmus, constipation and rectal bleeding. The digital rectal exploration showed a large lesion of hard consistency, occupying the lumen, with the presence of splinters that "pierced" the endoscopist's glove. Endoscopic examination and CTscan revealed an ulcerative exophytic neoplasia of the lower rectum in which multiple calcified areas were found. The lesion showed no bone involvement. An abdominal perineal resection sec Miles was performed. The histological examination revealed a highly cellular mesenchymal lesion, with spindle and epithelioid cells with moderate nuclear pleomorphism. The calcified component consisted of widespread osteoid deposition. The immunohistochemical investigations of neoplastic cells showed strong positivity for vimentin and osteonectin. The definitive histological diagnosis of primary extraskeletal osteosarcoma arising from the colon-rectum was made. To our knowledge, only one previous case of colonic osteosarcoma was published in the literature in 2001, reported by Shimazu and other authors. The extreme rarity of the tumor at this location, also confirmed by morphological and immunohistochemical data, prompted us to present this case report and to review the literature.
Copyright © 2013 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23642451     DOI: 10.1016/j.prp.2013.03.010

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  9 in total

Review 1.  Targeting Cancer Metabolism and Current Anti-Cancer Drugs.

Authors:  Witchuda Sukjoi; Jarunya Ngamkham; Paul V Attwood; Sarawut Jitrapakdee
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Extraskeletal osteosarcoma arising in myositis ossificans: a case report and review of the literature.

Authors:  Deepika Savant; Shachar Kenan; Samuel Kenan; Leonard Kahn
Journal:  Skeletal Radiol       Date:  2017-05-23       Impact factor: 2.199

3.  A Primary Extraskeletal Osteosarcoma of the Spleen: Rare Case Report.

Authors:  Xian Pan; Han-Lu Wang; Shi-Ming Lin; Jia-Li Lin; Dan-Dan Ruan; Jian-Hui Zhang; Ting Chen; Jie-Wei Luo; Zhu-Ting Fang
Journal:  Front Oncol       Date:  2022-05-02       Impact factor: 5.738

4.  Isocitrate dehydrogenase 1-mutated cancers are sensitive to the green tea polyphenol epigallocatechin-3-gallate.

Authors:  Tom H Peeters; Krissie Lenting; Vincent Breukels; Sanne A M van Lith; Corina N A M van den Heuvel; Remco Molenaar; Arno van Rooij; Ron Wevers; Paul N Span; Arend Heerschap; William P J Leenders
Journal:  Cancer Metab       Date:  2019-05-20

5.  Risk and clinicopathological features of osteosarcoma metastasis to the lung: A population-based study.

Authors:  Xiaoyi Huang; Jian Zhao; Jinyi Bai; Hua Shen; Bingbing Zhang; Lulu Deng; Chen Sun; Yanfang Liu; Jing Zhang; Jianming Zheng
Journal:  J Bone Oncol       Date:  2019-03-07       Impact factor: 4.072

6.  Anal extraskeletal osteosarcoma in a man: a case report and review of the literature.

Authors:  Ramin Saadaat; Jamshid Abdul-Ghafar; Nasir Ud Din; Ahmed Maseh Haidary
Journal:  J Med Case Rep       Date:  2020-04-20

7.  Identification of key biomarkers and functional pathways in osteosarcomas with lung metastasis: Evidence from bioinformatics analysis.

Authors:  Denghua Liu; Rui Zhou; Aiguo Zhou
Journal:  Medicine (Baltimore)       Date:  2021-02-12       Impact factor: 1.817

8.  Differentiation of Pelvic Osteosarcoma and Ewing Sarcoma Using Radiomic Analysis Based on T2-Weighted Images and Contrast-Enhanced T1-Weighted Images.

Authors:  Yi Dai; Ping Yin; Ning Mao; Chao Sun; Jiangfen Wu; Guanxun Cheng; Nan Hong
Journal:  Biomed Res Int       Date:  2020-05-11       Impact factor: 3.411

9.  Low GNG12 Expression Predicts Adverse Outcomes: A Potential Therapeutic Target for Osteosarcoma.

Authors:  Jinghong Yuan; Zhao Yuan; Aifang Ye; Tianlong Wu; Jingyu Jia; Jia Guo; Jian Zhang; Tao Li; Xigao Cheng
Journal:  Front Immunol       Date:  2021-10-06       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.